Fig. 7
From: Sertaconazole-repurposed nanoplatform enhances lung cancer therapy via CD44-targeted drug delivery
The biocompatibility of HTS NPs in vivo. (A) Body weight of different groups of tumor-bearing BALB/c nude mice (n = 5). (B-E) The serum biochemistry analysis (AST (B); ALT (C); CREA (D); UREA (E)) of mice with different treatments (n = 3). (F) The H&E staining of the major organs in mice after different treatments (Scale bars = 50 μm). All data are shown as mean ± SD and are representative of 3 independent experiments. The error bars represent the means ± SD (n = 5)